INVA
Innoviva, Inc.Company Information
- Company Name
- Innoviva, Inc.
- CIK
- CIK0001080014
- Category
- Large accelerated filer
- Ticker: Exchange
- INVA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- INVA
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-06-15
- Last sale
- 2025-03-06
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 1,196,746
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 74,306,662
- Shares outstanding
- 73,421,000
- Ownership
- 101.21%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- 2.24%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 570 | 603 | 551 | 477 | 398 | 319 | 305 | 261 | 217 | 178 | 194 | 180 | ||||||
| Accounts Receivable Net | 51 | 34 | 35 | 30 | 21 | 17 | 20 | 31 | 27 | 14 | 14 | 11 | ||||||
| Receivables Long Term Contracts Or Programs | 60 | 59 | 58 | 63 | 67 | 61 | 66 | 61 | 67 | 62 | 70 | 57 | ||||||
| Inventory Net | 39 | 39 | 39 | 38 | 49 | 41 | 34 | 34 | 37 | 37 | 41 | 41 | ||||||
| Prepaid Expense And Other Assets Current | 24 | 25 | 27 | 19 | 17 | 15 | 21 | 13 | 8 | 17 | 22 | 15 | ||||||
| Other Assets Current | 0 | 4 | 2 | 0 | 0 | 0 | 1 | 2 | 2 | 3 | 4 | 2 | ||||||
| Assets Current | 753 | 773 | 728 | 685 | 652 | 582 | 554 | 401 | 358 | 311 | 344 | 305 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Long Term Investments | 441 | 413 | 404 | 344 | 297 | 291 | 342 | 434 | 445 | 477 | 444 | 422 | ||||||
| Capitalized Contract Cost Net | 49 | 53 | 56 | 60 | 63 | 67 | 70 | 73 | 77 | 80 | 84 | 87 | ||||||
| Operating Lease Right Of Use Asset | 10 | 11 | 11 | 1 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | ||||||
| Goodwill | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | ||||||
| Intangible Assets Net Excluding Goodwill | 169 | 176 | 182 | 189 | 195 | 202 | 208 | 211 | 217 | 224 | 230 | 237 | ||||||
| Deferred Income Tax Assets Net | - | - | 0 | 8 | 13 | 12 | 12 | 15 | 11 | - | 0 | 5 | ||||||
| Other Assets Noncurrent | 40 | 41 | 41 | 41 | 41 | 41 | 41 | 3 | 3 | 3 | 3 | 3 | ||||||
| Assets | 1,703 | 1,837 | 1,635 | 1,429 | 1,334 | 1,254 | 1,301 | 1,232 | 1,225 | 1,268 | 1,244 | 1,188 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 4 | 7 | 5 | 6 | 5 | 5 | 2 | 4 | 2 | 1 | 7 | 4 | ||||||
| Employee Related Liabilities Current | 7 | 4 | 9 | 7 | 5 | 4 | 7 | 6 | 5 | 3 | 7 | 5 | ||||||
| Interest Payable Current | 2 | 0 | 2 | 0 | 3 | 1 | 3 | 1 | 3 | 1 | 3 | 1 | ||||||
| Deferred Revenue Current | 6 | 4 | 4 | 14 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Convertible Debt Current | - | - | - | - | - | - | - | 192 | - | - | 0 | 0 | ||||||
| Accrued Income Taxes Current | 0 | 0 | 0 | - | - | 2 | 0 | 3 | - | - | 0 | 0 | ||||||
| Debt Current | - | - | 0 | 0 | 192 | 192 | 192 | - | - | - | 0 | - | ||||||
| Accrued Liabilities And Other Liabilities | 29 | 22 | 29 | 22 | 38 | 31 | 30 | 18 | 17 | 24 | 20 | 25 | ||||||
| Liabilities Current | 47 | 37 | 50 | 48 | 247 | 235 | 236 | 224 | 28 | 30 | 38 | 36 | ||||||
| Long Term Debt Noncurrent | 258 | 258 | 258 | 257 | 257 | 257 | 256 | 256 | 447 | 447 | 446 | 446 | ||||||
| Other Liabilities Noncurrent | 67 | 69 | 66 | 57 | 60 | 62 | 64 | 71 | 72 | 72 | 72 | 69 | ||||||
| Deferred Income Tax Liabilities Net | 37 | 73 | 32 | - | - | - | 0 | 0 | 0 | 4 | 1 | 0 | ||||||
| Accrued Income Taxes Noncurrent | 60 | 58 | 57 | 56 | 55 | 54 | 53 | 12 | - | - | 12 | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Value | - | - | - | - | - | - | 0 | 0 | 0 | -394 | -394 | -394 | ||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Additional Paid In Capital Common Stock | 860 | 885 | 903 | 904 | 699 | 695 | 692 | 690 | 688 | 1,086 | 1,093 | 1,107 | ||||||
| Retained Earnings Accumulated Deficit | 373 | 456 | 269 | 105 | 15 | -48 | -2 | -22 | -23 | 11 | -25 | -87 | ||||||
| Stockholders Equity | 1,233 | 1,342 | 1,173 | 1,010 | 715 | 647 | 691 | 669 | 666 | 704 | 675 | 627 | ||||||
| Liabilities And Stockholders Equity | 1,703 | 1,837 | 1,635 | 1,429 | 1,334 | 1,254 | 1,301 | 1,232 | 1,225 | 1,268 | 1,244 | 1,188 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 73 | 74 | 75 | 75 | 63 | 63 | 63 | 63 | 63 | 63 | 63 | 64 | ||||||
| Shares Outstanding | 73 | 74 | 75 | 75 | 63 | 63 | 63 | 63 | 63 | 63 | 63 | 64 | ||||||
| Treasury Stock Common Shares | - | - | - | - | - | - | 0 | 0 | 0 | 32 | 32 | 32 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialInnoviva, Inc. (INVA) — SEC Financial Statements & Analysis
Innoviva, Inc. (INVA) is a pharmaceutical preparations company, incorporated in DE. Innoviva, Inc. trades on Nasdaq as: INVA. Innoviva, Inc. (INVA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, Innoviva, Inc. carries a market cap of $1.67B, a P/E ratio of 4.67x, a P/B ratio of 1.35x, a P/S ratio of 6.29x, an enterprise value of $1.36B, and an EV/EBITDA multiple of 7.17x. On profitability, it posts a gross margin of 119.80%, an operating margin of 61.31%, a net margin of 134.73%, a Return on Equity (ROE) of 36.68%, a Return on Assets (ROA) of 23.53%, and a Return on Invested Capital (ROIC) of 14.07%. Per share, it reports EPS of $4.87, diluted EPS of $4.87, free cash flow per share of $2.58, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 4.70% year-over-year, net income growth of 824.31% year-over-year, and EPS growth of 691.42% year-over-year. On the balance sheet, it maintains a current ratio of 16.01x, a quick ratio of 14.66x, working capital of $706.30M, a debt-to-equity ratio of 0.04x, a debt ratio of 0.03, an interest coverage ratio of 8.92x, free cash flow of $189.44M (TTM), and net debt of $-311.93M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.67B
- P/E TTM
- 4.67x
- EPS TTM
- $4.87
- P/B TTM
- 1.35x
- ROE TTM
- 36.68%
- ROA TTM
- 23.53%
- Debt To Equity
- 0.04x
- Free Cash Flow TTM
- $189.44M
- Net Revenue TTM Growth 1Y
- 4.70%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Innoviva, Inc. in?
Innoviva, Inc. (INVA) operates in the Pharmaceutical Preparations industry.
What exchange does INVA trade on?
Innoviva, Inc. (INVA) trades on the Nasdaq.
Where is Innoviva, Inc. incorporated?
Innoviva, Inc. is incorporated in DE.
When was Innoviva, Inc. (INVA)'s most recent SEC filing?
Innoviva, Inc. (INVA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is INVA's market cap?
Innoviva, Inc. (INVA) has a market capitalization of $1.67B as of 2026-06-30.
What is INVA's P/E ratio?
Innoviva, Inc. (INVA)'s trailing twelve month P/E ratio is 4.67x as of 2026-06-30.
What is INVA's EPS (earnings per share)?
Innoviva, Inc. (INVA)'s trailing twelve month EPS is $4.87 as of 2026-06-30.
What is INVA's ROE (return on equity)?
Innoviva, Inc. (INVA)'s trailing twelve month Return on Equity (ROE) is 36.68% as of 2026-06-30.
What is INVA's ROA (return on assets)?
Innoviva, Inc. (INVA)'s trailing twelve month Return on Assets (ROA) is 23.53% as of 2026-06-30.
What is INVA's ROIC (return on invested capital)?
Innoviva, Inc. (INVA)'s trailing twelve month Return on Invested Capital (ROIC) is 14.07% as of 2026-06-30.
What is INVA's EV/EBITDA?
Innoviva, Inc. (INVA)'s trailing twelve month EV/EBITDA is 7.17x as of 2026-06-30.